Salvatore Alesci - Takeda Pharmaceutical Member Policy
TKD Stock | EUR 25.32 0.07 0.28% |
Insider
Salvatore Alesci is Member Policy of Takeda Pharmaceutical
Phone | 81 3 3278 2111 |
Web | https://www.takeda.com |
Takeda Pharmaceutical Management Efficiency
The company has return on total asset (ROA) of 0.0247 % which means that it generated a profit of $0.0247 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0477 %, meaning that it generated $0.0477 on every $100 dollars invested by stockholders. Takeda Pharmaceutical's management efficiency ratios could be used to measure how well Takeda Pharmaceutical manages its routine affairs as well as how well it operates its assets and liabilities.Takeda Pharmaceutical has accumulated 4.14 T in total debt with debt to equity ratio (D/E) of 114.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Takeda Pharmaceutical has a current ratio of 1.2, suggesting that it may have difficulties to pay its financial obligations in time and when they become due. Debt can assist Takeda Pharmaceutical until it has trouble settling it off, either with new capital or with free cash flow. So, Takeda Pharmaceutical's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Takeda Pharmaceutical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Takeda to invest in growth at high rates of return. When we think about Takeda Pharmaceutical's use of debt, we should always consider it together with cash and equity.
Similar Executives
Showing other executives | INSIDER Age | ||
Jay Snowden | Penn National Gaming | 47 | |
Christine LaBombard | Penn National Gaming | 53 | |
Richard Primus | Penn National Gaming | N/A | |
Harper Ko | Penn National Gaming | 49 | |
Massimiliano Chiara | International Game Technology | 54 | |
Todd George | Penn National Gaming | 53 | |
Dorothy Costa | International Game Technology | 51 | |
Wendy Hamilton | Penn National Gaming | N/A | |
Felicia Hendrix | Penn National Gaming | 54 | |
Timothy Rishton | International Game Technology | 57 | |
Albert Britton | Penn National Gaming | 66 | |
Jennifer Weissman | Penn National Gaming | N/A | |
Ken Bossingham | International Game Technology | 59 | |
James Hurley | International Game Technology | N/A | |
Eric Schippers | Penn National Gaming | N/A |
Management Performance
Return On Equity | 0.0477 | |||
Return On Asset | 0.0247 |
Takeda Pharmaceutical Leadership Team
Elected by the shareholders, the Takeda Pharmaceutical's board of directors comprises two types of representatives: Takeda Pharmaceutical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Takeda. The board's role is to monitor Takeda Pharmaceutical's management team and ensure that shareholders' interests are well served. Takeda Pharmaceutical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Takeda Pharmaceutical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Christophe Weber, CEO Pres | ||
Christopher OReilly, Global Fin | ||
Andrew Plump, Pres Director | ||
Seigo Izumo, Chair Board | ||
Gabriele Ricci, Chief Officer | ||
Salvatore Alesci, Member Policy | ||
Iwaaki Taniguchi, Sr Department | ||
Constantine Saroukos, CFO Director | ||
Haruhiko Hirate, Member Board | ||
Norimasa Takeda, Chief Controller |
Takeda Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Takeda Pharmaceutical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.0477 | |||
Return On Asset | 0.0247 | |||
Profit Margin | 0.07 % | |||
Operating Margin | 0.13 % | |||
Current Valuation | 71.16 B | |||
Shares Outstanding | 1.56 B | |||
Shares Owned By Insiders | 1.20 % | |||
Shares Owned By Institutions | 41.30 % | |||
Price To Earning | 19.43 X | |||
Price To Book | 0.95 X |
Currently Active Assets on Macroaxis
BTC | Bitcoin | |
TRX | TRON | |
BNB | Binance Coin | |
ADA | Cardano | |
XRP | XRP |
Other Information on Investing in Takeda Stock
Takeda Pharmaceutical financial ratios help investors to determine whether Takeda Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Takeda with respect to the benefits of owning Takeda Pharmaceutical security.